Comparisons
BPC-157 versus TB-500
BPC-157 and TB-500 are two separately listed research materials, and one is a fragment rather than a full-length protein. A non-clinical reference on how.
4 min read
Research & analysis
Research guides, compound comparisons and laboratory documentation for European readers.
No articles match. Try another compound or choose all topics.
Research
Kisspeptin-10 and KISS1R
Explore human kisspeptin-10’s sequence, molecular formula, amidated structure and KISS1R mechanism, with primary sources and clear research limits.
3 min read
Quality & testing
Reading a Semax purity report
Read a Semax purity report by separating HPLC peak area, identity and measured content. Check the batch, method and documentation without assuming a result.
2 min read
Quality & testing
Peptide storage records
Start with the exact material and its documentation. A useful storage record preserves what was known at receipt and what happened afterwards.
3 min read
Comparisons
5-Amino-1MQ versus SLU-PP-332
Compare 5-Amino-1MQ and SLU-PP-332 in plain English: different small molecules, different targets and the limits of metabolic research claims.
4 min read
Explore the library
Research, explained. Evidence, in context.
Research news
Australia's Synedica peptide warning
Australian testing found Synedica peptide products contained no TB-500 and less retatrutide than labelled. The TGA has told Australians to discard them.
2 min read
Research news
Avexitide and the LUCIDITY trial
Why does avexitide block GLP-1? Explore post-bariatric hypoglycemia, LUCIDITY results and Amylyx’s November 2026 FDA-filing and conference plans.
3 min read
Buying guides
Bacteriostatic water formats
Compare bacteriostatic water formats, labelled amounts and documentation. See EPS format details and what to check before comparing final EUR quotes.
3 min read
Research
BPC-157 research explained
A plain-English guide to BPC-157: what the studies measured, what a 10mg vial label means, and how to distinguish evidence from unsupported claims.
4 min read
Buying guides
BPC-157 vial sizes and prices
Compare bpc-157 vial sizes and prices, labelled amounts and documentation. See EPS format details and what to check before comparing final EUR quotes.
3 min read
Research news
BPC-157: UK and US regulatory context
The October 2026 US peptide policy is not UK authorisation. Read the MHRA classification framework and why research-use wording cannot settle a product's.
3 min read
Research news
CagriSema versus tirzepatide
Read CagriSema's REIMAGINE 5 results, the exact tirzepatide comparator, trial population and US regulatory status checked in November 2026.
3 min read
Buying guides
CJC-1295 and ipamorelin blend prices
Compare cjc-1295 and ipamorelin blend prices, labelled amounts and documentation. See EPS format details and what to check before comparing final EUR quotes.
3 min read
Comparisons
CJC-1295: DAC, no DAC and blends
Compare standalone CJC-1295 with DAC, no DAC and Ipamorelin with a two-ingredient blend. Check the exact listing, component amounts and report.
4 min read
Buying guides
Comparing research peptide prices
Compare research peptide prices, labelled amounts and documentation. See EPS format details and what to check before comparing final EUR quotes.
3 min read
Research news
CT-G32 versus retatrutide
Explore CT-G32/SCO-940’s four-pathway design, the reported rat comparison with retatrutide and what a planned US FDA IND does: and does not: mean.
3 min read
Research news
Dundee's peptide discovery research
Dundee's new mass-spectrometry platform aims to identify immune-presented peptides from small tissue samples. What the October 2026 announcement establishes.
3 min read
Research news
Eloralintide and the EloraTZP trial
Understand Lilly's eloralintide and tirzepatide EloraTZP Phase 2b study, the population tested, combination results, tolerability and development stage.
3 min read
Research
Epitalon structure and telomere studies
Understand epitalon’s AEDG sequence, molecular formula and telomerase research, including the distinction between cell-culture findings and human outcomes.
3 min read
Research
Five research peptides compared
HHS named six peptides in a US draft policy. What KPV, MOTS-c, TB-500, Semax, Epitalon and BPC-157 are as molecules, and what HHS said about the evidence.
2 min read
Buying guides
GHK-Cu 50 mg versus 100 mg
Compare ghk-cu 50 mg versus 100 mg, labelled amounts and documentation. See EPS format details and what to check before comparing final EUR quotes.
3 min read
Research
GHK-Cu research explained
An evidence-tiered review of the GHK-Cu literature: in-vitro, animal and human findings, who produced them, and what cannot be concluded from them.
5 min read
Comparisons
GLOW versus KLOW blends
Compare GLOW and KLOW peptide ingredients, 50mg and 80mg labels, component amounts and what to check on each blend’s lab report.
3 min read
Comparisons
GLP-1 medicines and research materials
Why receptor targets, peptide identity, study evidence and the status of a supplied research material are separate questions.
3 min read
Research
GLP-1s, visceral fat and inflammation
Understand visceral fat, liver fat, body weight and inflammation markers, and how to read GLP-1 study results without confusing those outcomes.
4 min read
Research
Glutathione and redox chemistry
What glutathione is, why it is called a peptide, the difference between the reduced and oxidised forms, and what a batch certificate for it can show.
3 min read
Research
How BPC-157 works in studies
How does BPC-157 work? A simple look at cell signals, blood-vessel studies and the questions scientists still cannot answer about its mechanism.
3 min read
Research
How GHK-Cu interacts with cells
The proposed mechanism of GHK-Cu, the molecular targets implicated, and which steps are demonstrated rather than inferred.
5 min read
Research
How KPV interacts with cells
KPV contains just three amino acids. Learn how researchers studied its entry into cells, the signals they measured and what remains uncertain.
3 min read
Research
How MOTS-c affects cell signalling
MOTS-c is studied for its role in how cells handle changes in energy. This plain-English guide explains the main experiments and their limits.
3 min read
Research
How retatrutide targets three receptors
How retatrutide is proposed to act at the GIP, GLP-1 and glucagon receptors, which steps are demonstrated and which are inferred.
4 min read
Research
How tesamorelin's mechanism works
The proposed mechanism of tesamorelin, the molecular targets implicated, and which steps are demonstrated rather than inferred.
6 min read
Buying guides
How to compare peptide suppliers
Compare peptide suppliers, labelled amounts and documentation. See EPS format details and what to check before comparing final EUR quotes.
5 min read
Quality & testing
How to read a peptide COA
A useful certificate connects a result to a specific sample. Here is how to keep the compound, batch, method and measured amount together.
3 min read
Research news
Icotrokinra and the ANTHEM-UC trial
Read the ANTHEM-UC icotrokinra results: clinical response versus remission, safety findings and how ulcerative-colitis research differs from Icotyde approval.
3 min read
Research
Ipamorelin structure and mechanism
Explore ipamorelin’s pentapeptide sequence, D-amino acids, terminal amide and ghrelin-receptor mechanism, with primary pharmacology and human PK/PD sources.
3 min read
Comparisons
Ipamorelin, CJC-1295 and sermorelin
How these names differ, why CJC-1295 DAC data cannot be transferred to a no-DAC listing, and what to check in a blended research material.
3 min read
Research
KPV research and evidence
Learn what KPV means, what cell and animal studies examined, and why findings about one ingredient do not validate a KLOW blend.
4 min read
Research news
MariTide's MARITIME trial programme
Read the November 2026 MariTide update: antibody-peptide design, MARITIME-SWITCH, earlier Phase 2 results and the limits of monthly weight-loss claims.
3 min read
Comparisons
Melanotan I versus melanotan II
One is linear, selective and a licensed medicine under another name. The other is cyclic, non-selective and never licensed. The structural and regulatory.
3 min read
Research
Melanotan II adverse-effect reports
The adverse events reported in early studies and in case reports of unlicensed Melanotan II use, with the evidence tier of each, and what cannot be.
2 min read
Research
Melanotan II research explained
What Melanotan II is, how it relates to alpha-MSH, which melanocortin receptors it binds, and why it has never been a licensed medicine anywhere.
3 min read
Research news
MHRA's Birmingham fake-pen seizure
The MHRA Birmingham raid on 14 October 2026 seized over 12,000 fake retatrutide and tirzepatide pens worth about £2 million. What was found.
2 min read
Comparisons
MOTS-c versus SS-31
Compare SS-31/elamipretide and MOTS-c: different identities, mitochondrial research, Forzinity’s specific approval, vial sizes and lab-report checks.
3 min read
Buying guides
MOTS-c vial sizes and prices
Compare mots-c vial sizes and prices, labelled amounts and documentation. See EPS format details and what to check before comparing final EUR quotes.
3 min read
Research
NAD+ research explained
Understand NAD+ in plain English, distinguish it from NADH, NR and NMN, and check what longevity studies and vial lab reports actually show.
4 min read
Buying guides
NAD+ vial formats and pricing
Compare nad+ vial formats and pricing, labelled amounts and documentation. See EPS format details and what to check before comparing final EUR quotes.
2 min read
Comparisons
NAD+, NMN and NR compared
Three molecules on one metabolic pathway, often confused. Their structures, how cells convert one into another, and how each is regulated as a food.
3 min read
Research news
Oral semaglutide: the US changes
Is oral Ozempic available? Compare Ozempic tablets, Rybelsus and Wegovy pill, their US indications, formulation differences and the 2026 name change.
3 min read
Research news
Oral VK2735 and the SUNRISE trials
Understand oral VK2735's SUNRISE-1 and SUNRISE-2 Phase 3 studies, their populations, endpoints and how they differ from injectable VK2735 trials.
3 min read
Research news
Pemvidutide and the RECLAIM trial
Understand pemvidutide’s RECLAIM Phase 2 alcohol-use-disorder trial, heavy-drinking-day results, adverse events and the November 2026 AASLD update.
3 min read
Lab guides
Peptide concentration: mg and mL
Understand mg/mL calculations, unit conversions and the difference between a labelled amount and measured content in laboratory solutions.
3 min read
Lab guides
Peptide formulations and study routes
Compare peptide formulations and study routes by material, model and measured exposure. Understand why a research vial differs from a finished medicine.
3 min read
Research news
Peptide safety: UK warnings
Are peptides safe? UK bodies separate licensed peptide medicines from unregulated products. What BCAM and the MHRA warned about during 2026.
2 min read
Lab guides
Peptide sample preparation
Understand laboratory peptide reconstitution, solvent compatibility, concentration and storage records, without assuming one method fits every compound.
4 min read
Comparisons
Peptide vials versus pens
Understand peptide vial and pen formats, milligrams per vial versus concentration, and why packaging does not establish medicine approval.
4 min read
Research news
Peptides and the 2027 WADA list
What WADA's 2027 peptide clarification means, which restrictions already apply in 2026, and why a missing compound name does not establish permission in.
3 min read
Research news
Peptides and UK medicines law
The Human Medicines Regulations 2012 decide when a peptide counts as a medicine in the UK. What regulations 2 and 46 say, in plain English.
2 min read
Research news
Petrelintide and ZUPREME-2
Read petrelintide's October 2026 ZUPREME-2 results, its amylin mechanism, study population, tolerability findings and the next development stage.
3 min read
Research news
Retatrutide and TRIUMPH-4
Understand retatrutide’s TRIUMPH-4 knee-pain results, the placebo comparison, trial population, safety findings and what ACR 2026 adds.
3 min read
Research
Retatrutide research evidence
Retatrutide evidence by study type, including the October 2026 Ozempic comparator announcement, registry details and limits of sponsor-reported trial.
6 min read
Research
Retatrutide side effects in trials
Which adverse events were reported in published retatrutide trials, how often, and what those trials can and cannot tell you.
3 min read
Research news
Retatrutide versus Ozempic: trial data
Read the October 2026 TRANSCEND-T2D-2 retatrutide versus Ozempic results, study design, outcome estimates and limits of the sponsor announcement.
3 min read
Buying guides
Retatrutide vial sizes and prices
Compare retatrutide vial sizes and prices, labelled amounts and documentation. See EPS format details and what to check before comparing final EUR quotes.
3 min read
Comparisons
Retatrutide, tirzepatide and semaglutide
Compare retatrutide, tirzepatide and semaglutide by receptor targets, clinical evidence and product status, with clear explanations of trial comparisons.
4 min read
Research news
Retatrutide's UK development status
Retatrutide in the UK has no licence and no release date. What the MHRA said after its October raid and where Lilly's filing plans stand.
2 min read
Research news
Richard Norton: the coroner's findings
A coroner found Richard Norton died from complications of using unapproved CJC1295 and Ipamorelin, and asked the TGA to consider further restrictions.
2 min read
Research news
Rusfertide, Mimrylo and VERIFY
Understand rusfertide (Mimrylo), its FDA-approved polycythemia-vera indication, the VERIFY trial’s hematocrit outcomes and important evidence limitations.
3 min read
Research
Selank research explained
What Selank is, where it comes from, how it is classified, and what published research does and does not establish.
3 min read
Research
Semax research and evidence
An evidence-tiered review of the Semax literature: in-vitro, animal and human findings, and what cannot be concluded from them.
6 min read
Comparisons
Semax versus Selank
Compare Semax and Selank without the jargon: different peptides, different study outcomes, testing questions and limits on focus or calm claims.
4 min read
Research
Senolytics and senescent cells
Senolytics selectively trigger cell death in senescent 'zombie' cells. What senescent cells are, how senolytics are classified, and where immunity fits.
2 min read
Research news
SenoMune-0257's first human study
Immorta Bio reported first human administration of SenoMune-0257 in November 2026. Read the study setting, senescence context and remaining evidence gaps.
3 min read
Research
SS-31 and mitochondrial membranes
SS-31 is studied for its interactions with mitochondrial membranes. A simple guide to the four-part peptide, the experiments and their limits.
3 min read
Comparisons
Sterile versus bacteriostatic water
Sterile water and bacteriostatic water are different reagents, and the difference is a preservative. A non-clinical reference on reagent identity and.
3 min read
Research
TB-500 versus thymosin beta-4
Understand TB-500 and thymosin beta-4 naming, full-length versus fragment identities, and the batch-report checks needed for a 10mg listing.
4 min read
Buying guides
TB-500 vial sizes and prices
Compare tb-500 vial sizes and prices, labelled amounts and documentation. See EPS format details and what to check before comparing final EUR quotes.
3 min read
Research
Tesamorelin research explained
What tesamorelin is, how it is classified, its development status, and what published research does and does not establish.
3 min read
Buying guides
Tesamorelin vial sizes and prices
Compare tesamorelin vial sizes and prices, labelled amounts and documentation. See EPS format details and what to check before comparing final EUR quotes.
3 min read
Research news
The FDA's RonanRx GLP-1 warning
Read the FDA’s RonanRx warning in context: compounded semaglutide and tirzepatide, approval claims, manufacturer identity and product-origin language.
3 min read
Research news
The Lilly and Hims access agreement
What the November 2026 Lilly: Hims agreement changes for Zepbound and Foundayo, and how branded GLP-1 access differs from Peptides+ and compounded drugs.
3 min read
Research news
The MHRA peptide-clinic investigation
UK peptide clinics have been under MHRA review since April 2026. What triggered the investigation, what BCAM warned and what has happened since.
2 min read
Research news
The UK research-use-only debate
A senior academic wants the UK to tighten the research use only loophole on peptides. What Dr Luke Turnock said and how the MHRA responded.
2 min read
Research news
Tirzepatide and Taltz trial results
Explore the TOGETHER-PsA 52-week results for tirzepatide plus Taltz, including ACR50, the comparator, safety reporting and limits of the analysis.
3 min read
Research
Tirzepatide research explained
What tirzepatide is, which receptors it was designed for, how it differs from the licensed medicine of the same name, and what the published trial.
4 min read
Comparisons
Tirzepatide versus semaglutide
The two molecules differ in sequence origin, receptor coverage and lipid chain, and the published head-to-head trials compare the medicines, not research.
3 min read
Buying guides
Tirzepatide vial sizes and prices
Compare tirzepatide vial sizes and prices, labelled amounts and documentation. See EPS format details and what to check before comparing final EUR quotes.
3 min read
Research news
UK peptide news: the 2026 timeline
Peptides UK news in 2026 in date order: from the MHRA clinic probe in April to the Birmingham raid in October, with every source linked.
2 min read
Research
Understanding retatrutide vial labels
What a retatrutide research vial contains, what 10mg looks like, and how to check a vial against its batch certificate.
2 min read
Research news
US peptide compounding policy in 2026
What HHS's October 2026 peptide draft says about BPC-157 and five other compounds, its proposed conditions, and how it differs from FDA approval.
3 min read
Research
Weight-loss peptide evidence
Understand weight-loss peptide claims by separating approved formulations, clinical studies, experimental findings and different measures of body fat.
4 min read
Research
What are peptides?
Learn what peptides are, why the term appears in medicines and skincare, and how to read vial labels, purity claims and certificates of analysis.
4 min read
Research news
What Hims announced for Peptides+
What Hims & Hers announced about Peptides+ on October 29, 2026, which therapies remain planned, and how pharmacy access differs from FDA approval.
3 min read
Quality & testing
What HPLC purity means
A chromatographic percentage and the amount in a vial are different measurements. Read the method before comparing the number.
3 min read
Research
What is in the KLOW blend?
What KLOW Research Blend contains, how its 80mg figure is documented, and what published research does and does not establish.
3 min read
Research
What is MOTS-c?
What MOTS-c is, how it is classified, its development status, and what published research does and does not establish.
3 min read
Research
What is retatrutide?
What retatrutide is, how it is classified, where its development stands, and what published research does and does not establish.
4 min read
Research news
What the ASA found in peptide adverts
The ASA rated 43% of the research peptide ads it assessed as high risk. What its Pulse Report says about 'research use only' wording and how ads were sold.
2 min read
Research
What third-party peptide testing shows
Check what third-party peptide testing covers: sample selection, batch matching, identity, amount, purity, sterility and endotoxins.
4 min read
Research news
Zenagamtide and the AMAZE 9 trial
Learn what zenagamtide, formerly amycretin, is and what the oral AMAZE 9 Phase 3 trial measures. Compare the trial with earlier oral diabetes research.
3 min read
Images show EPS packaging concepts.